Mustafa Khasraw, MBChB, MD, FRCP, FRACP

Quick facts

Phase 2 pipeline

• Unpulsed DCs

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Mustafa Khasraw, MBChB, MD, FRCP, FRACP portfolio CI brief
• Mustafa Khasraw, MBChB, MD, FRCP, FRACP pipeline updates RSS

Related

• Sector hub: All tracked pharma companies